Cubist Systematic Strategies’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$26.2M Buy
206,642
+64,722
+46% +$7.7M 0.13% 197
2025
Q2
$17.4M Buy
141,920
+103,419
+269% +$11.8M 0.08% 346
2025
Q1
$3.9M Sell
38,501
-18,714
-33% -$1.83M 0.02% 1033
2024
Q4
$5.28M Buy
+57,215
New +$5.62M 0.03% 804
2024
Q3
Sell
-83,347
Closed -$7.15M 3114
2024
Q2
$7.15M Buy
83,347
+73,683
+762% +$6.18M 0.05% 576
2024
Q1
$798K Buy
9,664
+8,694
+896% +$637K ﹤0.01% 2337
2023
Q4
$64.7K Sell
970
-12,309
-93% -$797K ﹤0.01% 3243
2023
Q3
$892K Sell
13,279
-3,733
-22% -$257K 0.01% 1968
2023
Q2
$1.15M Sell
17,012
-167,927
-91% -$10.5M 0.01% 1867
2023
Q1
$10M Buy
184,939
+160,745
+664% +$9.36M 0.06% 455
2022
Q4
$1.45M Buy
24,194
+22,220
+1,126% +$1.21M 0.01% 2124
2022
Q3
$89K Sell
1,974
-126,995
-98% -$6.35M ﹤0.01% 4046
2022
Q2
$5.75M Buy
128,969
+105,834
+457% +$5.43M 0.04% 862
2022
Q1
$1.31M Sell
23,135
-54,531
-70% -$2.85M 0.01% 1820
2021
Q4
$4.03M Sell
77,666
-80,111
-51% -$4.13M 0.04% 807
2021
Q3
$9.42M Buy
157,777
+51,361
+48% +$3.23M 0.12% 205
2021
Q2
$6.61M Buy
106,416
+54,346
+104% +$3.62M 0.07% 389
2021
Q1
$3.39M Buy
52,070
+34,961
+204% +$2.28M 0.04% 670
2020
Q4
$1.13M Buy
17,109
+11,830
+224% +$696K 0.02% 1311
2020
Q3
$273K Sell
5,279
-86,578
-94% -$4.44M ﹤0.01% 2020
2020
Q2
$4.53M Buy
91,857
+64,101
+231% +$3.46M 0.08% 397
2020
Q1
$1.41M Sell
27,756
-140,140
-83% -$8.08M 0.04% 633
2019
Q4
$9.25M Buy
167,896
+163,535
+3,750% +$8.87M 0.17% 118
2019
Q3
$220K Sell
4,361
-133,816
-97% -$6.72M ﹤0.01% 1728
2019
Q2
$6.96M Buy
138,177
+8,259
+6% +$401K 0.13% 199
2019
Q1
$6.04M Buy
129,918
+69,383
+115% +$3.51M 0.2% 90
2018
Q4
$2.97M Buy
60,535
+33,909
+127% +$1.93M 0.14% 148
2018
Q3
$1.65M Buy
26,626
+13,871
+109% +$843K 0.09% 282
2018
Q2
$687K Buy
12,755
+3,048
+31% +$152K 0.03% 645
2018
Q1
$441K Sell
9,707
-7,769
-44% -$333K 0.03% 887
2017
Q4
$687K Sell
17,476
-1,164
-6% -$44.3K 0.04% 695
2017
Q3
$687K Buy
+18,640
New +$664K 0.04% 627
2017
Q2
Sell
-11,945
Closed -$407K 1723
2017
Q1
$407K Sell
11,945
-6,210
-34% -$204K 0.03% 753
2016
Q4
$596K Buy
18,155
+9,465
+109% +$307K 0.05% 583
2016
Q3
$280K Buy
8,690
+328
+4% +$10.6K 0.02% 1049
2016
Q2
$258K Buy
+8,362
New +$262K 0.02% 1169
2015
Q3
Sell
-11,132
Closed -$408K 1889
2015
Q2
$408K Buy
+11,132
New +$397K 0.02% 1055
2015
Q1
Sell
-66,287
Closed -$2.03M 1935
2014
Q4
$2.03M Buy
+66,287
New +$2.07M 0.11% 235

Other funds holding EHC

Cubist Systematic Strategies's EHC Position: Q3 2025 in Review

Cubist Systematic Strategies increased its Encompass Health (EHC) stake by 46% in Q3 2025, buying an estimated $7.7M and bringing the position to 206,642 shares worth $26.2M. The position accounts for 0.13% of the portfolio, ranked #197.

Cubist Systematic Strategies first reported a position in EHC in Q4 2014 and has held it in 38 quarters since. 604 funds tracked by Wall St. Rank hold EHC as of Q3 2025.

  • Cubist Systematic Strategies held 206,642 shares of Encompass Health worth $26.2M as of Q3 2025.
  • Cubist Systematic Strategies bought 64,722 Encompass Health shares in Q3 2025, an estimated $7.7M.
  • Encompass Health made up 0.13% of Cubist Systematic Strategies's portfolio in Q3 2025, its #197 holding.
  • Cubist Systematic Strategies first reported a position in Encompass Health in Q4 2014 and has held it in 38 quarters since.
  • 604 funds tracked by Wall St. Rank held Encompass Health as of Q3 2025.

Based on Cubist Systematic Strategies's 13F filing for Q3 2025, filed 14 Nov 2025.